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Abstract
Background: The World Health Organization recommends dry cord care for newborns but this recommendation may
not be optimal in low resource settings where most births take place in an unclean environment and infections account
for up to half of neonatal deaths. A previous trial in Nepal indicated that umbilical cord cleansing with 4.0% chlorhexidine
could substantially reduce mortality and omphalitis risk, but policy changes await additional community-based data.
Methods: The Projahnmo Chlorhexidine study was a three-year, cluster-randomized, community-based trial to assess
the impact of three cord care regimens on neonatal mortality and omphalitis. Women were recruited mid-pregnancy,
received a basic package of maternal and neonatal health promotion messages, and were followed to pregnancy outcome.
Newborns were visited at home by local village-based workers whose areas were randomized to either 1) single- or 2)
7-day cord cleansing with 4.0% chlorhexidine, or 3) promotion of dry cord care as recommended by WHO. All mothers
received basic messages regarding hand-washing, clean cord cutting, and avoidance of harmful home-base applications to
the cord. Death within 28 days and omphalitis were the primary outcomes; these were monitored directly through home
visits by community health workers on days 1, 3, 6, 9, 15, and 28 after birth.
Discussion: Due to report in early 2010, the Projahnmo Chlorhexidine Study examines the impact of multiple or single
chlorhexidine cleansing of the cord on neonatal mortality and omphalitis among newborns of rural Sylhet District,
Bangladesh. The results of this trial will be interpreted in conjunction with a similarly designed trial previously conducted
in Nepal, and will have implications for policy guidelines for optimal cord care of newborns in low resource settings in
Asia.
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Background
Of the annual 3.7 million global neonatal deaths, almost
all (99%) occur in developing countries, and one-third to
one half are attributed to infections[1] such as sepsis,
meningitis, pneumonia, omphalitis, tetanus, and
diarrhea. In settings where home delivery is common and
attendance by skilled personnel is low, many babies are
born in unhygienic conditions and infections of the
umbilical cord stump are common [2,3]. Exposure of the
freshly cut umbilical cord stump to pathogens on the cut-
ting instrument, on the hands of caretakers, or elsewhere
in the environment leads to local cord infections (ompha-
litis) that may progress to systemic infection and death [2-
4]. Alternatively, during the period immediately following
birth, while the vessels of the umbilical cord remain pat-
ent, direct exposure to the bloodstream via the cord may
lead to systemic infection without any visible signs of
local cord infection [5].
The World Health Organization (WHO) currently recom-
mends keeping the cord clean and dry. The guidelines do
not include a universal recommendation for application
of any topical antiseptic, although their potential role is
acknowledged for settings where harmful practices are
common [2]. Practical and effective implementation of
this guidance, however, is challenging in both hospital
and community-based low resource settings and is often
less than optimal. Recently, there has been increased
interest in both the overall role of exposure of the cord
stump to invasive pathogens and the potential benefit of
topical cord cleansing with chlorhexidine[6], a safe and
effective broad-spectrum antiseptic[7].
A large community-based trial[8] in rural southern Nepal
conducted between 2002 and 2006 randomized babies
within clusters to receive one of three cord care regimens:
(1) 4.0% chlorhexidine cleansing for 7 of the first 10 days
after birth or (2) soap and water cleansing for 7 of the first
10 days after birth, or (3) dry cord care. Mothers of all
infants received educational messages about hygienic
cord care (e.g., hand-washing, clean cutting, and avoid-
ance of harmful topical applications). Depending on the
severity of infection, omphalitis incidence was reduced by
32-75% among infants receiving chlorhexidine compared
to those in the dry cord care group. Overall, mortality
among enrolled infants was 24% lower in the chlorhexi-
dine group compared to dry cord care. About two-thirds
of the infants were reached within 24 hours of birth and
evidence of a protective benefit of chlorhexidine cleansing
among this subset was increased. Chlorhexidine cleansing
reduced severe infection by 87% and mortality by 34%
among those enrolled within 24 hours, while no differ-
ence between the groups was observed when cord cleans-
ing was initiated after 24 hours[8].
An expert consultative meeting convened in Washington,
DC shortly after completion of the Nepal trial concluded
that, prior to any changes in policy, at least one replica-
tion trial in South Asia would be necessary to expand the
evidence base for chlorhexidine cleansing of the cord[9].
Two specific questions were noted. First, would a similar
beneficial effect of multiple cleansings of the cord through
the first week of life be observed in a separate but similar
population? Second, can a simpler regimen of cord
cleansing only once and as soon as possible after birth,
provide a similar protective benefit against omphalitis
and mortality? Answering this second question is neces-
sary as the intensive intervention (cleansing on 7 of first
10 days of life) followed in the Nepal efficacy trial might
not be easily implemented in most programmatic set-
tings, given associated logistical and financial barriers for
outreach health workers. Furthermore, even if the inter-
vention was delivered by caretakers themselves, compli-
ance with the promoted instructions might be increased if
the more simple recommendation of one-time cleansing
as soon as possible after birth could be given. Moreover, a
single application of antiseptic to the cord could more
readily be incorporated into clean birth kits.
Thus, in addition to replicating the question of efficacy of
multiple (i.e. daily for 7 days) cord cleansing with chlo-
rhexidine (4%, as used in Nepal), it was deemed essential
to also investigate the potential efficacy of a single appli-
cation as soon as possible after birth. The second major
research activity for the Projahnmo study site in rural Syl-
het District of north eastern Bangladesh was designed to
answer these questions and provide evidence to inform
global guidelines for optimal umbilical cord care of new-
borns. In this manuscript, we discuss in detail the design
and implementation of this community-based cluster ran-
domized trial, including study site, randomization and
intervention delivery procedures, follow-up data collec-
tion, and analysis plans.
Methods/Design
Trial Design and Preparation
Aim
This community-based trial in Sylhet, Bangladesh was
designed to assess the impact of chlorhexidine cleansing
on neonatal mortality and omphalitis. Specifically, these
outcomes were compared among babies randomly
assigned within clusters to one of three cord care regi-
mens:  1) Multiple Chlorhexidine Cleansing Group:
Neonates received cleansing of the cord with 4.0% chlo-
rhexidine as soon as possible after birth and on subse-
quent days until age 7 days; 2) Single Chlorhexidine
Cleansing Group: Neonates received a single cleansing of
the cord with 4.0% chlorhexidine as soon as possible after
birth. 3) Dry Cord Care Group: Neonates in this group
received no specific umbilical cord care ("dry cord care",BMC Pediatrics 2009, 9:67 http://www.biomedcentral.com/1471-2431/9/67
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as recommended by WHO) beyond the basic messages
related to clean cord cutting and avoiding home-based
applications to the cord, which were directed to all
groups. Mothers and newborns in all three groups also
received a basic community-based package of essential
newborn care (described below).
Study Site
This study was conducted in three sub-districts (upazillas)
of Sylhet District (Zakiganj, Khanaighat, Beanibazar) of
north eastern Bangladesh. This is the research site of Pro-
jahnmo, a collaboration of the Johns Hopkins Bloomberg
School of Public Health, the International Centre for Diar-
rhoeal Disease Research, Bangladesh (ICDDR,B), the Min-
istry of Health of the Government of Bangladesh, and
Shimantik http://www.shimantik.org, a non-governmen-
tal organization. In the first Projahnmo study, details of
which have been previously published[10], 24 unions (a
government-defined administrative sub-unit of the upa-
zilla, of approximately 20,000 population) in this region
were randomized to one of three arms. Two arms received
a newborn care intervention, delivered either through
community-mobilization activities or a more intensive
home-care approach (pregnancy and postnatal visits),
while the third arm received currently available care, and
served as the comparison arm. In the home-care arm,
community-based health workers (CHWs) were addition-
ally trained to assess newborns for severe illnesses and
refer or treat sick newborns. In that trial, neonatal mortal-
ity was reduced by 34% in the home-care arm relative to
the comparison arm[10]. This study site and the home-
care intervention including essential newborn care pro-
motion and follow-up assessments of newborns formed
the basis of the infrastructure and service provision upon
which the Projahnmo Chlorhexidine Study was imple-
mented.
Study Population and Surveillance Infrastructure
Six lower mortality unions of the original 24 Projahnmo
unions were excluded, and 4 additional higher-mortality
unions from Khanaighat were added, leaving 22 total
unions for participation in the study (Figure 1 - Map). The
Map of Sylhet District, Bangladesh and unions participating in the Projahnmo Chlorhexidine Study Figure 1
Map of Sylhet District, Bangladesh and unions participating in the Projahnmo Chlorhexidine Study.BMC Pediatrics 2009, 9:67 http://www.biomedcentral.com/1471-2431/9/67
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study population for the Projahnmo Chlorhexidine Study
was defined as all live-born infants delivered in these 22
unions, and the total population was approximately
546,000 with an expected annual birth cohort of 12,000
to 13,000 babies. Prior to the initiation of trial activities,
the project team undertook a community mapping and
household enumeration exercise to delineate the CHW
surveillance areas that served as the clusters for this trial.
CHW surveillance areas were pre-established for 6 unions
(33 CHW areas) that had participated in the home-care
arm of the previous trial. The remaining 18 unions had
either previously participated in the community-care arm
(5 unions) or comparison area (7 unions), or were new
expanded areas (4 unions). In these 18 unions, delinea-
tion of new CHW areas was required, and the mapping/
enumeration process resulted in 32, 40, and 28 CHW
areas in the former community care, comparison, and the
new expanded areas, respectively. Over the 133 total study
clusters, the mean population size and standard deviation
was 4,108 and 633, respectively (range: 2,071 - 5,598).
Each defined CHW area (cluster) was further divided
based on population size into 4-5 village-based sub-sec-
tions of approximately 1000 population (~200 house-
holds) each. Within each cluster, a locally resident female
CHW was recruited and trained in all aspects of the study.
Similarly, within each of the cluster sub-sections (n =
590), a single female village-based health worker (VHW)
was identified to assist directly with delivery of the cord
care intervention.
Randomization
The unit of randomization was the CHW area (n = 133);
105 of these had participated in one of the three arms of
the previous Projahnmo project (home-based care: n = 33;
community-care: n = 32 clusters; comparison arm: n = 40
clusters). As there were differences in neonatal risk within
these three strata during the previous study, the allocation
of clusters in the current study was done separately within
each of these strata to facilitate balance in baseline neona-
tal mortality risk. A fourth stratum was defined for the
remaining 28 clusters from the expanded area (i.e. not
participating in the previous project). A random alloca-
tion sequence for each stratum was done using a compu-
ter-generated procedure (STATA version 9.2, StataCorp.,
College Station, TX, USA). Within strata, clusters were ran-
domly allocated to multiple cleansing, single cleansing, or
dry cord care arms using the procedure with a constant
block size of three. The distribution of clusters over the
three allocation groups and previous project participation
status, along with numbers of VHWs is shown in Table 1.
Workers and participants in the study were not masked to
group allocation.
Preparation of Chlorhexidine
At regular intervals, 20% chlorhexidine digluconate was
purchased in bulk from ACI Limited, Bangladesh and
transferred to Sylhet in 5 litre containers. The source man-
ufacturer for ACI was Vipor Chemicals PVT. LTD http://
www.viporchem.com based in Baroda, India. A Projah-
nmo worker prepared the diluted 4.0% chlorhexidine
solution for use in the trial, by mixing distilled water (645
ml/litre) with the stock solution (355 ml/litre) to the
appropriate concentration (7.1% of the total digluconate
salt); this was identical to the dilution process in the pre-
vious Nepal trial. The diluted solution was individually
packaged into 70 ml and 10 ml opaque bottles for distri-
bution to VHWs in the multiple and single cleansing
Table 1: Characteristics of the clusters participating in the Projahnmo Chlorhexidine Study and distribution across study arm and 
previous project status
Multiple Cleansing Single Cleansing Dry Cord Care Arm Overall
Total Number 45 44 44 133
Previous Projahnmo Status
- Home Care Arm 11 11 11 33
- Community Care Arm 11 10 11 32
- Comparison Arm 14 13 13 40
- Expanded Areas 91 0 9 2 8
Total Population Size 188,479 177,110 180,880 546,469
Mean Population Size 4,188 4,025 4,110 4,108
Number of VHW areas 202 195 193 590BMC Pediatrics 2009, 9:67 http://www.biomedcentral.com/1471-2431/9/67
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groups, respectively. For each batch of prepared solutions,
5 bottles were randomly selected, transferred to a collabo-
rating pharmaceutical laboratory at Eskayef Bangladesh
Limited, and analyzed for final CHX concentration.
Trial Implementation
Enrolment of Pregnant Women and Basic Intervention Package
Identification and recruitment of pregnant women was
based on regular monitoring by CHWs of printed registers
containing the names and locations all married women of
reproductive age (MWRA) within their individual target
areas. Workers updated the list of MWRA and ascertained
the pregnancy status of all women on the register by con-
ducting an informal survey of each household in their
area once every 8 weeks. The study was explained, partici-
pation offered, and informed consent provided to each
newly pregnant women identified through this monitor-
ing process. Those agreeing to participate provided data
including age, parity, date of last menstrual period, occu-
pation, literacy, abbreviated birth history, and socio-eco-
nomic information about the household.
Participating women were provided with a basic package
of maternal and newborn health promotion messages and
interventions, delivered at two home visits during preg-
nancy. The first of these sessions was conducted at the
same time as the recruitment visit at about 3-4 months of
pregnancy; the second occurred at approximately the 8th
month of pregnancy. At each session, messages and coun-
selling were provided regarding pregnancy care (antenatal
care-seeking, tetanus toxoid immunization, iron/folic
acid supplementation, and recognition of danger signs
during pregnancy and at the time of delivery), identifica-
tion and selection of a birth attendant, clean and hygienic
delivery, early and exclusive breastfeeding, thermal care of
the newborn, and postnatal danger signs and care-seek-
ing. All families were provided a clean birthing kit and the
use of items in the kit was explained through demonstra-
tion at these pregnancy visits.
Sessions during pregnancy provided opportunities to
establish the process for notification of project workers
regarding pregnancy outcomes, and to reinforce the
importance of accomplishing this as rapidly as possible.
By accompanying the CHWs on their two pregnancy
home visits, the VHWs were able to orient the family
members on the process of sending a message to the VHW
via a family member or another individual when the preg-
nant women began labor. Compliance with this notifica-
tion system was strengthened by explaining that rapid
notification would enable faster assessment of the health
of the baby by the CHW.
Chlorhexidine Intervention
After being notified of an ongoing labor or recent delivery,
the local VHW travelled to the home of the newborn to
deliver the assigned intervention. Depending on the cord
care regimen randomly allocated to that location (i.e.
cluster), the VHW either provided the standard set of dry
cord care promotional messages (dry cord care group) or
applied the initial cleansing of the cord (single and multi-
ple cleansing groups). VHWs in all  groups visited the
home of the newborn daily through the first week of life
(i.e. 7 days) and basic messages about cord hygiene were
promoted across all the groups at these visits. In addition,
the VHW provided the chlorhexidine cleansing interven-
tion at each visit in the multiple-cleansing arm, and at the
first visit only in the single-cleansing arm. Each individual
VHW consistently followed only one set of procedures
throughout the trial period, as the unit of randomization
was the area (cluster) of the VHW's supervising CHW. The
VHW recorded the date and approximate time of visits,
the vital status of the baby (alive/dead), and the status of
the intervention for that day (provided, refused) on a pic-
torial form.
For newborns receiving chlorhexidine interventions (i.e.
arms 1 and 2), the basic cleansing procedure followed by
the VHW on day 1 was consistent with how the interven-
tion was delivered in the previous community-based trial
in rural Nepal[8]. First, the VHW washed her hands with
soap and water and allowed them to air dry. If the baby
was wrapped or clothed, the VHW removed an amount of
covering necessary to expose the cord stump area. She
moistened a cotton swab by placing it on the mouth of the
chlorhexidine bottle (10 ml or 70 ml bottle, depending
on study allocation) and inverting the bottle. The worker
then gently dabbed the abdominal skin around the base
and cord stump thoroughly, ensuring that the entire area
was covered with solution. A second cotton swab was sim-
ilarly moistened and used to cleanse the tip of the cord (if
not yet separated) or the middle of the cord stump (if sep-
aration had occurred). After cleansing the cord, the VHW
wrapped the baby warmly and placed the baby in the arms
of the mother or other family member. Emphasis was
placed on thoroughly completing the cleansing procedure
as quickly as possibly, followed by prompt wrapping of
the baby.
Follow-up Visits
In all clusters, after conducting the first visit after birth, the
VHW notified their supervising CHW through direct com-
munication, mobile phone, or secondary messenger. The
supervising CHW then visited the home to initiate the
neonatal follow-up and assessment schedule. At the first
follow-up visit by the CHW (day 1), basic information
regarding the characteristics of labor and delivery and
morbidity prior to, during, and after delivery was
recorded. Newborn-specific data collected at this visit
included date and time of birth, sex, weight of the infant,
and care given during and immediately after birth (bath-
ing, massage, breastfeeding practices). At this first visitBMC Pediatrics 2009, 9:67 http://www.biomedcentral.com/1471-2431/9/67
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and subsequent assessment visits (days 3, 6, 9, 15) the
CHW assessed the status of the newborn through a com-
bination of direct observation (vital status, axillary tem-
perature, chest indrawing, umbilical and skin infection,
jaundice, lethargy, respiratory rate, etc) and questions
directed to the mother regarding signs of morbidity of the
infant and care-seeking since the prior visit (or since
birth).
A particular focus was placed on assessing signs of umbil-
ical cord infection. Previous community-based work in
Nepal[11] and Tanzania[12] utilized a standard set of fifty
digital images of umbilical cords with varying degrees of
inflammation to assess intra- and inter-worker agreement
in recognition of signs and to estimate sensitivity and spe-
cificity of workers compared to a physician gold standard
ranking of the images. Following this model, CHWs were
trained to recognize and classify the severity of three signs
of infection: redness, pus, and swelling, and their skills
were evaluated through repeated (quarterly) assessment
of these images. Results were used to identify those CHWs
needing more focused one-on-one training.
A sign-based algorithm [13] was followed by the CHWs to
identify sick newborns and refer them for care. In the 33
clusters from the home-care arm of the previous research
study, CHWs also had the capacity to treat newborns at
home with injectable antibiotics, following procedures
that have been previously described[14]; these clusters
were balanced across the three cord care regimens (11
clusters in each arm of this study, Table 1). At a final visit
conducted between 28 and 35 days after birth, the CHW
recorded the vital status of the baby.
Any neonatal death occurring during the period of follow-
up was recorded; at regular intervals a database-generated
list of recent deaths were distributed to supervisory staff
responsible fro conducting an in-depth verbal autopsy. An
automated algorithm utilized sign-based cause-of-death
definitions to assign multiple and/or single cause of death
to each infant, using both hierarchical and non-hierarchi-
cal assignment [15].
Outcomes, Sample Size, and Analysis
Eligibility and Enrolment Criteria
All live born babies in the study area were eligible for the
study (Figure 2). Babies were enrolled if 1) they were alive
at the time of the VHWs first home visit and 2) this first
visit occurred within 7 days after birth. All enrolled babies
will be included in the primary intent-to-treat analysis,
regardless of the status of receipt of the allocated interven-
tion. Some pregnant women delivered in a location other
than the location where the initial pregnancy was identi-
fied and data were collected. For example, in this region
approximately 15% of women move late in pregnancy in
order to deliver in their maternal home and 10-12%
deliver in a health facility. In this trial, all neonates were
assigned the treatment code corresponding to the cluster
in which they were born, regardless of whether or not the
birth cluster matched the one in which the mother was
first enrolled. Infants born in a facility were enrolled in
the cluster in which they were first met after returning
from the facility. That is, infants born alive in a facility
were considered eligible, and were included in the pri-
mary analysis if enrolled (i.e. if they were met at home by
a project worker during the first seven days of life).
Outcome Measures
The two primary outcomes of this trial were neonatal
mortality and omphalitis among live born enrolled
infants. Neonatal mortality was defined as death within
the first 28 days after birth and the sample size calculation
(see Sample Size) was based on detection of mortality dif-
ference among enrolled infants. Omphalitis was defined
under various sign-based algorithms representing mild,
moderate, and severe omphalitis[11,12]. Other a priori
planned outcome analyses include 1) an assessment of
the impact of the intervention on these outcomes among
the entire sample of live born infants, including those that
died before they had an opportunity to be enrolled in the
trial, 2) analyses stratified by birth weight status (<2500
grams vs. > 2500 grams), gestational age (<37 weeks vs.
>37 weeks), timing of initiation of intervention, and 3)
analyses conditioned on survival to various time points
(i.e. 24 hours, 48 hours, etc).
Sample size
We hypothesized that single- or multiple-umbilical cord
cleansing with 4.0% chlorhexidine solution would result
in a 20-30% reduction in neonatal mortality among
enrolled infants, based on reductions observed in the pre-
vious Nepal trial. Sample size calculations were based on
20% Type II error (80% power), 5% Type I error, and10%
loss to follow-up, and the presumed design effect (1.2)
was estimated from mean cluster size and coefficient of
variation from the previous Projahnmo activities. The
expected neonatal mortality rate (NMR) in the dry cord
care group was estimated at 36/1000, which accounted for
a 30% reduction in NMR expected after implementing the
basic package across all 133 clusters. As not all infants
were expected to be met immediately at birth, sample size
calculations were based on assuming that a proportion of
NMR would occur prior to enrolment. Varying this pro-
portion and the overall desired detectable reduction in
mortality among enrolled infants enabled estimation of
required sample sizes (Table 2). We ultimately assumed
that 20% of neonatal deaths would occur prior to enrol-
ment, requiring approximately 28,797 newborns (9,600
in each group) to detect a difference of 25% in mortality
among enrolled infants. A power curve displaying the
power to detect a range of differences under this fixed
sample size is shown in Figure 3. At a rate of 12,500 birthsBMC Pediatrics 2009, 9:67 http://www.biomedcentral.com/1471-2431/9/67
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per year, we expected to fully enrol the required number
within 2.3 years. Due to the size of the study area and the
large number of clusters, the trial initiation was phased-in
across the 133 clusters between June and December of
2007; the staggered implementation was balanced on
treatment groups.
Data Management and Analysis
CHWs collected data using maternal-level forms during
their routine area monitoring and the two pregnancy vis-
its, and infant-level forms during their follow-up visits to
the newborns. The VHW-collected pictorial information
on intervention visits in the first 7 days of life (date, time,
visit status) was confirmed by CHWs through discussion
with family members and then transferred to the infant-
level forms maintained by the CHWs. All forms were
checked for completeness daily by CHWs and at fort-
nightly meetings with supervisory staff, and then trans-
ferred to Dhaka for entry into a customized Microsoft SQL
Server database. Entry programs included standard range
and validation checks. Selected process-related data varia-
bles were entered at the field level to enable rapid feed-
back on essential implementation variables (e.g.
enrolment, coverage and timing of home visits, etc.) to the
field level supervisory staff.
For the final (and interim) analyses descriptive statistics
on enrolment rates, timing of intervention delivery, fre-
quency and coverage of home visits, receipt of compo-
nents of the basic package, reported care practices, and
health and demographic characteristics of newborn,
mother, and households will be examined for balance
Trial Design Flowchart Figure 2
Trial Design Flowchart.
Power to detect a range of differences in mortality risk  between group Figure 3
Power to detect a range of differences in mortality 
risk between group.BMC Pediatrics 2009, 9:67 http://www.biomedcentral.com/1471-2431/9/67
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across the groups. The primary impact analyses will follow
an intent-to-treat approach among all enrolled infants,
and will focus on comparing the mortality experience of
newborns across the three cord care regimen groups. The
mortality rate per 1000 live births will be estimated for all
groups, and risk of death in each of the intervention
groups (multiple and single cleansing) relative to the dry
cord care group will be calculated. Standard errors will be
adjusted for the clustered allocation using the generalized
estimating equation approach[16], and 95% confidence
intervals will be estimated. If necessary, adjusted models
will be constructed to account for any imbalance between
the groups.
Individual signs of cord infection and omphalitis under
three sign-based algorithms (mild, moderate, severe) will
be compared between groups using similar regression
models with adjustment for both clustered design and
multiple measures per baby. Individual visit level cord
assessment data will be collapsed over the neonatal
period with binary indicators created for each of the sign-
based algorithms to estimate cumulative incidence of cord
infection and risk of omphalitis relative to the compari-
son dry cord group.
Data Safety and Monitoring Board and Interim Analyses
An independent Data Safety Monitoring Board (DSMB)
consisting of national and regional experts was estab-
lished. Interim analyses were conducted after 31.3%
(March 2008) and 69.8% (January 2009) of the expected
sample size was recruited. These data were presented to
the DSMB in both electronic reports and face-to-face
meetings in Dhaka, Bangladesh. Stopping guidelines for
efficacy were agreed upon by the DSMB members and the
investigating team prior to the trial, using Lan-DeMets
boundaries and nominal p-values for group sequential
analyses estimated using O'Brien/Fleming spending func-
tion[17,18]. At each of the meetings, the DSMB recom-
mended continuation of the project as originally planned.
Approvals
The study protocol was approved by the Institutional
Review Board of the Johns Hopkins Bloomberg School of
Public Health and the Ethical Review Committee of the
International Centre for Diarrheal Disease Research,
Bangladesh (ICDDR,B). The protocol has been reviewed
and re-approved on an annual basis since 2007.
Discussion
Due to report in early 2010, the Projahnmo Chlorhexi-
dine Study will provide an evaluation of the impact of
multiple- or single cord cleansing with 4.0% chlorhexi-
dine relative to the current WHO recommended dry cord
care on neonatal mortality and omphalitis. The results
from this trial will expand the evidence base for the use of
topical chlorhexidine as a low-cost, simple-to-deliver
intervention, and it's potential to reduce neonatal mortal-
ity and morbidity in low resource settings. Furthermore, it
will provide new information on one-time cleansing of
the umbilical cord and its potential effect relative to mul-
tiple cleansing. Since the chlorhexidine intervention was
implemented in the context of a basic package of maternal
and newborn care, this study will provide data on the
impact of chlorhexidine cleansing which is additional to
the effect of the basic package of care which is being scaled
up in Bangladesh.
Rural Sylhet District of Bangladesh is an appropriate loca-
tion for examining the impact of chlorhexidine interven-
tions, with strong potential for generalizing results to the
wider South Asian region. The rate of home births, overall
neonatal mortality rates, and the proportion of deaths
attributed to infection in this region are high and compa-
rable to large parts of Bangladesh, India, Nepal and Paki-
stan. Access to care and care-seeking by households is low
and identification of interventions that can improve sur-
vival and be delivered by community-based workers or
caretakers in the household is urgently needed. The exist-
ing Projahnmo Project provided a highly capable and
well-developed infrastructure for conducting a popula-
tion-based community trial. Most importantly, Projah-
nmo represents a strong partnership that includes the
Government of Bangladesh, local and international
research institutes and NGOs. This broad-based partner-
ship will increase the likelihood that if the intervention is
found successful, it will be incorporated into national pol-
icy recommendations and scaled up within Bangladesh.
Table 2: Total required number of newborns required for a range of detectable differences in mortality, by proportion of NMR 
occurring prior to enrolment
Detectable Difference in Mortality
Proportion of neonatal mortality occurring prior to enrolment 20% 25% 30%
10% 40643 25511 17367
20% 45883 28797 19602
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The data from this trial will be interpreted in conjunction
with the results from the previous Nepal trial and will fur-
ther inform ongoing discussions regarding current WHO
recommendation for dry cord care. Further community-
based trials are being planned for settings in sub-Saharan
Africa, and lessons learned from the design and imple-
mentation of this trial might provide guidance to the con-
duct of those trials. If the intervention is ultimately proven
successful, chlorhexidine cleansing of the cord can be rap-
idly incorporated into existing neonatal care promotion
programs and contribute to global efforts to improve new-
born survival.
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